Zolgensma Helps Mobility of SMA Children in Qatari Real-world Study

SMA News Today’s multimedia associate, Price Wooldridge, discusses how the gene therapy Zolgensma helps improve mobility in young children with Spinal Muscular Atrophy (SMA) in a real-world study.

Also, as August is beyond half over several stories have been featured in the 31 Days of SMA campaign. Here are a handful of the most recent ones.

Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/